Posted by Michael Wonder on 13 Aug 2021
GC Pharma announces GreenGene F approval in China for the treatment of haemophilia A
12 August 2021 - GreenGene F now approved in China, provides more haemophilia A patients access to proven therapy.
GC Pharma today announced the approval of GreenGene F (beroctocog alfa) [recombinant human coagulation factor VIII for injection] for the control and prophylaxis of bleeding episodes in individuals with haemophilia A in China by the National Medical Products Administration.
GreenGene F was initially approved by the Korean health authority in 2010 for control and prevention of bleeding episodes in patients with haemophilia A.
